115 related articles for article (PubMed ID: 38479556)
21. Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease.
Pariyar R; Bastola T; Lee DH; Seo J
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216503
[TBL] [Abstract][Full Text] [Related]
22. Caspase-1 Deficiency Alleviates Dopaminergic Neuronal Death via Inhibiting Caspase-7/AIF Pathway in MPTP/p Mouse Model of Parkinson's Disease.
Qiao C; Zhang LX; Sun XY; Ding JH; Lu M; Hu G
Mol Neurobiol; 2017 Aug; 54(6):4292-4302. PubMed ID: 27339879
[TBL] [Abstract][Full Text] [Related]
23. Low Levels of Prohibitin in Substantia Nigra Makes Dopaminergic Neurons Vulnerable in Parkinson's Disease.
Dutta D; Ali N; Banerjee E; Singh R; Naskar A; Paidi RK; Mohanakumar KP
Mol Neurobiol; 2018 Jan; 55(1):804-821. PubMed ID: 28062948
[TBL] [Abstract][Full Text] [Related]
24. Silencing RNF13 Alleviates Parkinson's Disease - Like Problems in Mouse Models by Regulating the Endoplasmic Reticulum Stress-Mediated IRE1α-TRAF2-ASK1-JNK Pathway.
Ji M; Niu S; Guo J; Mi H; Jiang P
J Mol Neurosci; 2020 Dec; 70(12):1977-1986. PubMed ID: 32617872
[TBL] [Abstract][Full Text] [Related]
25. MiR-29c protects against inflammation and apoptosis in Parkinson's disease model in vivo and in vitro by targeting SP1.
Wang R; Yang Y; Wang H; He Y; Li C
Clin Exp Pharmacol Physiol; 2020 Mar; 47(3):372-382. PubMed ID: 31732967
[TBL] [Abstract][Full Text] [Related]
26. SNHG1 promotes MPP
Zhao J; Geng L; Chen Y; Wu C
Biol Res; 2020 Jan; 53(1):1. PubMed ID: 31907031
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-218-5p-Ddx41 axis restrains microglia-mediated neuroinflammation through downregulating type I interferon response in a mouse model of Parkinson's disease.
Wang D; Gao H; Qin Q; Li J; Zhao J; Qu Y; Li J; Xiong Y; Min Z; Mao Z; Xue Z
J Transl Med; 2024 Jan; 22(1):63. PubMed ID: 38229084
[TBL] [Abstract][Full Text] [Related]
28. MiR-212 Attenuates MPP⁺-Induced Neuronal Damage by Targeting KLF4 in SH-SY5Y Cells.
Song Y; Liu Y; Chen X
Yonsei Med J; 2018 May; 59(3):416-424. PubMed ID: 29611404
[TBL] [Abstract][Full Text] [Related]
29. NRF1 mitigates motor dysfunction and dopamine neuron degeneration in mice with Parkinson's disease by promoting GLRX m
Gong X; Huang M; Chen L
CNS Neurosci Ther; 2024 Mar; 30(3):e14441. PubMed ID: 37735974
[TBL] [Abstract][Full Text] [Related]
30. Berberine Attenuates MPP
Li X; Su Y; Li N; Zhang FR; Zhang N
Neurochem Res; 2021 Dec; 46(12):3286-3300. PubMed ID: 34427876
[TBL] [Abstract][Full Text] [Related]
31. 2-Aminoethoxydiphenyl borate ameliorates mitochondrial dysfunctions in MPTP/MPP
Vaidya B; Polepalli M; Sharma SS; Singh JN
Mitochondrion; 2023 Mar; 69():95-103. PubMed ID: 36758857
[TBL] [Abstract][Full Text] [Related]
32. Linalool, a Fragrance Compound in Plants, Protects Dopaminergic Neurons and Improves Motor Function and Skeletal Muscle Strength in Experimental Models of Parkinson's Disease.
Chang WH; Hsu HT; Lin CC; An LM; Lee CH; Ko HH; Lin CL; Lo YC
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473763
[TBL] [Abstract][Full Text] [Related]
33. Ndfip1 protected dopaminergic neurons via regulating mitochondrial function and ferroptosis in Parkinson's disease.
Fu X; Qu L; Xu H; Xie J
Exp Neurol; 2024 May; 375():114724. PubMed ID: 38365133
[TBL] [Abstract][Full Text] [Related]
34. Long noncoding RNA HAGLROS regulates apoptosis and autophagy in Parkinson's disease via regulating miR-100/ATG10 axis and PI3K/Akt/mTOR pathway activation.
Peng T; Liu X; Wang J; Liu Y; Fu Z; Ma X; Li J; Sun G; Ji Y; Lu J; Wan W; Lu H
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2764-2774. PubMed ID: 31298038
[TBL] [Abstract][Full Text] [Related]
35. Association of decreased triadin expression level with apoptosis of dopaminergic cells in Parkinson's disease mouse model.
Seo MH; Lim S; Yeo S
BMC Neurosci; 2021 Nov; 22(1):65. PubMed ID: 34736417
[TBL] [Abstract][Full Text] [Related]
36. Analysis of m6A modification regulators in the substantia nigra and striatum of MPTP-induced Parkinson's disease mice.
Yu Z; Huang L; Xia Y; Cheng S; Yang C; Chen C; Zou Z; Wang X; Tian X; Jiang X; Zhou L
Neurosci Lett; 2022 Nov; 791():136907. PubMed ID: 36209975
[TBL] [Abstract][Full Text] [Related]
37. STAT4 targets KISS1 to inhibit the oxidative damage, inflammation and neuronal apoptosis in experimental PD models by inactivating the MAPK pathway.
Zhang X; Wang Y; Lv J
Neurochem Int; 2024 May; 175():105683. PubMed ID: 38341034
[TBL] [Abstract][Full Text] [Related]
38. LncRNA HOTAIR promotes α-synuclein aggregation and apoptosis of SH-SY5Y cells by regulating miR-221-3p in Parkinson's disease.
Sun Q; Zhang Y; Wang S; Yang F; Cai H; Xing Y; Zhou L; Chen S; Wang Y
Exp Cell Res; 2022 Aug; 417(1):113132. PubMed ID: 35398161
[TBL] [Abstract][Full Text] [Related]
39. Amentoflavone protects dopaminergic neurons in MPTP-induced Parkinson's disease model mice through PI3K/Akt and ERK signaling pathways.
Cao Q; Qin L; Huang F; Wang X; Yang L; Shi H; Wu H; Zhang B; Chen Z; Wu X
Toxicol Appl Pharmacol; 2017 Mar; 319():80-90. PubMed ID: 28185818
[TBL] [Abstract][Full Text] [Related]
40. The peptidyl-prolyl isomerase Pin1 up-regulation and proapoptotic function in dopaminergic neurons: relevance to the pathogenesis of Parkinson disease.
Ghosh A; Saminathan H; Kanthasamy A; Anantharam V; Jin H; Sondarva G; Harischandra DS; Qian Z; Rana A; Kanthasamy AG
J Biol Chem; 2013 Jul; 288(30):21955-71. PubMed ID: 23754278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
